Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:26 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 2,064,000 9.800% |
-14,000 (-0.67%) |
Filing History |
| 2024-02-14 2:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Armistice Capital, LLC | 5,200,000 6.490% |
28,000 (+0.54%) |
Filing History |
| 2024-02-14 2:25 pm Purchase |
2023-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP |
Armistice Capital, LLC | 270 9.990% |
204 (+308.69%) |
Filing History |
| 2024-02-14 2:24 pm Purchase |
2023-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 2,715,635 9.990% |
1,728,424 (+175.08%) |
Filing History |
| 2024-02-14 2:24 pm Purchase |
2023-12-31 | 13G | ContraFect Corporation CFRXQ |
Armistice Capital, LLC | 1,395,093 9.990% |
1,395,093 (New Position) |
Filing History |
| 2024-02-14 2:23 pm Unchanged |
2023-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ |
Armistice Capital, LLC | 2,666,666 6.750% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:23 pm Purchase |
2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 1,078,459 9.990% |
122,464 (+12.81%) |
Filing History |
| 2024-02-14 2:22 pm Purchase |
2023-12-31 | 13G | Assertio Holdings, Inc. ASRT |
Armistice Capital, LLC | 5,800,000 6.130% |
5,800,000 (New Position) |
Filing History |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 4,626,190 9.990% |
1,629,079 (+54.35%) |
Filing History |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 3,524,000 6.310% |
774,000 (+28.15%) |
Filing History |
| 2023-06-27 6:02 pm Sale |
2023-06-26 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 2,597 4.990% |
-17,331 (-86.97%) |
Filing History |
| 2023-02-16 2:49 pm Sale |
2022-12-31 | 13G | Addex Therapeutics Ltd ADXN |
Armistice Capital, LLC | 33,765 4.990% |
-168,158 (-83.28%) |
Filing History |
| 2023-02-14 1:50 pm Purchase |
2022-12-31 | 13G | Midatech Pharma plc MTP |
Armistice Capital, LLC | 96,707 8.930% |
96,707 (New Position) |
Filing History |
| 2023-02-14 1:48 pm Purchase |
2022-12-31 | 13G | XORTX Therapeutics Inc. XRTX |
Armistice Capital, LLC | 18,550 9.990% |
18,550 (New Position) |
Filing History |
| 2023-02-14 1:47 pm Purchase |
2022-12-31 | 13G | Exicure, Inc. XCUR |
Armistice Capital, LLC | 52,149 4.990% |
52,149 (New Position) |
Filing History |
| 2023-02-14 1:44 pm Purchase |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 3,396,000 8.800% |
3,396,000 (New Position) |
Filing History |
| 2023-02-14 1:43 pm Purchase |
2022-12-31 | 13G | VivoPower International PLC VVPR |
Armistice Capital, LLC | 191,690 7.780% |
191,690 (New Position) |
Filing History |
| 2023-02-14 1:41 pm Purchase |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 976,000 6.080% |
176,000 (+22.00%) |
Filing History |
| 2023-02-14 1:39 pm Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 6,412,000 9.990% |
2,334,000 (+57.23%) |
Filing History |
| 2023-02-14 1:39 pm Purchase |
2022-12-31 | 13G | Trevena, Inc. TRVN |
Armistice Capital, LLC | 31,393 9.990% |
31,393 (New Position) |
Filing History |